| P2093 | author name string | Makoto Sumitomo | |
| | Kiyoshi Takahara | |
| | Ryoichi Shiroki | |
| | Kosuke Fukaya | |
| | Mamoru Kusaka | |
| | Naohiko Fukami | |
| | Kenji Zennami | |
| | Manabu Ichino | |
| | Takuhisa Nukaya | |
| | Hitomi Sasaki | |
| | Masaru Hikichi | |
| | Masashi Nishino | |
| | Takahito Jyoudai | |
| P2860 | cites work | Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 |
| | Natural history of progression after PSA elevation following radical prostatectomy | Q33611613 |
| | Radical prostatectomy or watchful waiting in early prostate cancer | Q33985455 |
| | Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers. | Q34143199 |
| | Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer | Q34288796 |
| | Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious | Q34617238 |
| | Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies | Q34934772 |
| | Evidence from robot-assisted laparoscopic radical prostatectomy: a systematic review | Q36541107 |
| | Outcomes of locally advanced (T3 or greater) prostate cancer in men undergoing robot-assisted laparoscopic prostatectomy | Q37582930 |
| | Biomarkers for prostate cancer detection | Q37656233 |
| | Robotic radical prostatectomy in patients with high-risk disease: a review of short-term outcomes from a high-volume center | Q37828531 |
| | High-risk prostate cancer: from definition to contemporary management | Q37990230 |
| | The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review | Q38110664 |
| | Positive surgical margins after radical prostatectomy: a systematic review and contemporary update | Q38128020 |
| | Radical prostatectomy or radiotherapy in high-risk prostate cancer: a systematic review and metaanalysis | Q38192818 |
| | The Risks and Benefits of Cavernous Neurovascular Bundle Sparing during Radical Prostatectomy: A Systematic Review and Meta-Analysis | Q38912413 |
| | Safety of selective nerve sparing in high risk prostate cancer during robot-assisted radical prostatectomy. | Q39583603 |
| | Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis | Q41436143 |
| | Surgical Techniques for Managing Post-prostatectomy Erectile Dysfunction | Q42368368 |
| | Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer | Q43432671 |
| | The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging | Q43784445 |
| | Effect of a risk-stratified grade of nerve-sparing technique on early return of continence after robot-assisted laparoscopic radical prostatectomy | Q44491152 |
| | Long-term evaluation of survival, continence and potency (SCP) outcomes after robot-assisted radical prostatectomy (RARP). | Q44595410 |
| | Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution | Q47329081 |
| | Robotic radical prostatectomy as the initial step in multimodal therapy for men with high-risk localised prostate cancer: initial experience of 160 men. | Q51521214 |
| | Nerve-sparing Surgery Technique, Not the Preservation of the Neurovascular Bundles, Leads to Improved Long-term Continence Rates After Radical Prostatectomy. | Q51807703 |
| | Robotic laparoscopic radical prostatectomy for biopsy Gleason 8 to 10: prediction of favorable pathologic outcome with preoperative parameters. | Q51873352 |
| | Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. | Q55067996 |
| | Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging | Q69737582 |
| | Anatomic radical prostatectomy: evolution of the surgical technique | Q77562491 |
| | Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer | Q78160795 |
| | Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy | Q80744531 |
| | Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy | Q92114312 |
| P433 | issue | 4 | |
| P304 | page(s) | 3896-3902 | |
| P577 | publication date | 2019-07-31 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Clinical and oncological outcomes of robot-assisted radical prostatectomy with nerve sparing vs. non-nerve sparing for high-risk prostate cancer cases | |
| P478 | volume | 18 | |